Edesa Biotech Inc (EDSA)
4.51
-0.02
(-0.44%)
USD |
NASDAQ |
May 15, 14:43
Edesa Biotech Accounts Receivable (Quarterly): 0.7436M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.7436M |
September 30, 2023 | 0.6265M |
June 30, 2023 | 0.0429M |
March 31, 2023 | 0.0502M |
December 31, 2022 | 0.1255M |
September 30, 2022 | 1.256M |
June 30, 2022 | 1.404M |
March 31, 2022 | 1.249M |
December 31, 2021 | 2.876M |
September 30, 2021 | 3.303M |
June 30, 2021 | 4.185M |
March 31, 2021 | 7.810M |
December 31, 2020 | 0.168M |
September 30, 2020 | 0.0874M |
June 30, 2020 | 0.0565M |
March 31, 2020 | 0.0841M |
December 31, 2019 | 0.1096M |
June 30, 2019 | 0.345M |
March 31, 2019 | 0.04M |
December 31, 2018 | 0.0717M |
September 30, 2018 | 0.0412M |
June 30, 2018 | 0.0103M |
March 31, 2018 | 0.0628M |
December 31, 2017 | 0.011M |
September 30, 2017 | 0.0013M |
Date | Value |
---|---|
June 30, 2017 | 0.0119M |
March 31, 2017 | 0.0659M |
December 31, 2016 | 0.0129M |
September 30, 2016 | 0.0858M |
June 30, 2016 | 0.009M |
March 31, 2016 | 0.0104M |
December 31, 2015 | 0.0356M |
September 30, 2015 | 0.1576M |
June 30, 2015 | 0.113M |
March 31, 2015 | 0.0166M |
December 31, 2014 | 0.036M |
August 31, 2014 | 0.0566M |
May 31, 2014 | 0.005M |
February 28, 2014 | 0.0506M |
November 30, 2013 | 0.0051M |
August 31, 2013 | 0.0176M |
May 31, 2013 | 0.005M |
February 28, 2013 | 0.005M |
November 30, 2012 | 0.0271M |
August 31, 2012 | 0.005M |
May 31, 2012 | 0.0463M |
February 29, 2012 | 0.0316M |
November 30, 2011 | 0.2282M |
August 31, 2011 | 0.004M |
May 31, 2011 | 0.0294M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.0429M
Minimum
Jun 2023
7.810M
Maximum
Mar 2021
1.362M
Average
0.4858M
Median
Accounts Receivable (Quarterly) Benchmarks
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | 24.09M |
Lexaria Bioscience Corp | -- |
Xenon Pharmaceuticals Inc | 0.833M |
ESSA Pharma Inc | 0.1806M |